Track NVCR and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Novocure Ltd
Neuhofstrasse 21, Baar, Switzerland, 6340
IPO
2015
Employees
1,605
Industry
Medical Devices
Sector
Healthcare
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q1 20267-7
0
Q3 20250+2
2
2-quarter cumulative
7 sells2 buys
Analyst Ratings
4 analysts covering
Buy50%recommend buy
Buy
2
Hold
2
Sell
0